SYNLAB Eesti OÜ

11107913

Company info

SYNLAB Eesti OÜ

11107913

SYNLAB Eestihttps://www.synlab.eeSYNLAB Eesti

SYNLAB Eesti on suurim meditsiinilabor Eestis, mis tegutseb juba aastast 1995.

General info

Name

SYNLAB Eesti OÜ

Registry code

11107913

VAT number

EE101243708

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

15.04.2005 (19)

Financial year

01.01-31.12

Capital

2 566.00 €

Activity

86902 - Activities of medical laboratories, blood banks, sperm banks and other similar banks

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

-

Annual report

Not submitted

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

Kaido Beljaev

11.12.1969 (54)

- Board member -

Rainar Aamisepp

09.02.1967 (57)

- Board member -

Icosagen AS

10565884

- - - Founder

Financial info

2019
31.10.2020
2020
28.11.2021
2021
18.07.2022
2022
30.06.2023
Total Revenue 26 960 826 € 73 640 268 € 104 462 114 € 64 880 605 €
Net profit (loss) for the period 4 271 711 € 27 488 475 € 38 217 513 € 14 661 609 €
Profit Margin 16% 37% 37% 23%
Current Assets 23 246 395 € 54 653 396 € 52 598 779 € 34 532 878 €
Fixed Assets 11 208 617 € 11 362 143 € 11 754 622 € 10 722 989 €
Total Assets 34 455 012 € 66 015 539 € 64 353 401 € 45 255 867 €
Current Liabilities 3 820 405 € 10 894 146 € 11 925 232 € 6 252 976 €
Non Current Liabilities 20 914 399 € 21 112 710 € 201 973 € 115 086 €
Total Liabilities 24 734 804 € 32 006 856 € 12 127 205 € 6 368 062 €
Share Capital - - - -
Equity 9 720 208 € 34 008 683 € 52 226 196 € 38 887 805 €
Employees 222 266 381 346

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 1 336 626.62 € 3 419 010.89 € 1 222 869.11 € 322
2023 Q4 1 035 756.04 € 1 233 471.04 € 1 139 214.42 € 319
2023 Q3 1 202 500.35 € 1 351 702.9 € 1 228 389.63 € 328
2023 Q2 998 347.47 € 1 548 878.03 € 1 492 853.31 € 332
2023 Q1 1 554 220.25 € 1 398 164.22 € 1 267 756.52 € 323
2022 Q4 2 514 421.1 € 7 910 676.48 € 1 267 680.41 € 378
2022 Q3 1 467 629.67 € 1 462 946.17 € 1 307 318.61 € 428
2022 Q2 1 925 435.26 € 2 030 162.05 € 1 862 921.66 € 451
2022 Q1 4 227 671.76 € 2 747 219.84 € 2 137 336.08 € 501
2021 Q4 3 415 907.07 € 6 928 817.32 € 1 473 688.61 € 543
2021 Q3 1 258 519.09 € 1 622 310.83 € 1 533 881.96 € 522
2021 Q2 1 690 107.35 € 2 495 469.93 € 2 400 702.45 € 517
2021 Q1 2 017 817.98 € 2 499 671 € 1 496 061.65 € 492
2020 Q4 5 216 886.61 € 1 422 516.69 € 1 344 177.53 € 439
2020 Q3 2 576 991.73 € 1 035 953.14 € 850 404.75 € 392
2020 Q2 2 005 287.09 € 1 121 183.02 € 851 160.56 € 309
2020 Q1 813 577.94 € 964 401.23 € 861 099.14 € 286